7073 results for "canc*"

in 12.53 milliseconds.

• Breast Cancer Cell Line Data Access Committee

  Dac EGAC00001000134

• The University of Hong Kong Gastric Cancer Genomics Study Data Access Committee

  Dac EGAC00001000136

• CUHK Liver Cancer Project DAC

  Dac EGAC00001000214

• Data Access Committee for German Consortium for Translational Cancer Research (DKTK)

  Dac EGAC00001000217

• Data Access Committee of divisions B060 and B062, German Cancer Research Center (DKFZ)

  Dac EGAC00001000219

• DAC for integrated genomics of metastatic prostate cancer

  Dac EGAC00001000230

• Memorial Sloan Kettering Cancer Center - Human Oncology & Pathogenesis Program (HOOP) - Data Access Committee

  Dac EGAC00001000305

• Asian lung cancer genome data

  Dac EGAC00001000248

• Institute for Refractory Cancer Research (IRCR) Data Access Committee

  Dac EGAC00001000272

• DAC for the study of response to EGFR Blockade in Colorectal Cancer

  Dac EGAC00001000360

• Radboud Pediatric Cancer Data Access Committee

  Dac EGAC00001000369

• DAC of Synergie Lyon Cancer

  Dac EGAC00001000382

• Data Access Committee for COLO829 Somatic reference standard for cancer genome sequencing

  Dac EGAC00001000408

• Data access committee of the Prostate Cancer Research Center, University of Tampere, Finland.

  Dac EGAC00001000423

• Data Access Committee for the Metastatic Breast Cancer Whole-exome sequencing study

  Dac EGAC00001000434

• Korean Gastric cancers data

  Dac EGAC00001000439

• Genetic predisposition to cancer, University of Tampere

  Dac EGAC00001000488

• Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins

  Dac EGAC00001000507

• Data access policy for PDTX Breast Cancer data from Bruna et al (2016), Cell.

  Dac EGAC00001000540

• DAC for Single Cell Transcriptomics of Colorectal Cancer

  Dac EGAC00001000550

• Peking University BIOPIC Data Access Committee (PUBDAC).The DATA ACCESS AGREEMENT is provided at https://github.com/zhangyybio/single-T-cell-data-access. Applicants can request access to the data by directly downloading it or by sending an email to cancerpku@pku.edu.cn. The process that is used to approve an application includes verifying the institution, participants and research purposes of the application. In general this process will take about two weeks. In principal, any academic research institutions complying with the laws and bioethic regulation policies of China will be approved.

  Dac EGAC00001000551

• Data access committee for study - The subclonal architecture of metastatic breast cancer: Results from a prospective community-based rapid autopsy program "CASCADE".

  Dac EGAC00001000574

• Dr. Fatima Mechta-Grigoriou, PhD, DR1 Head of Stress and Cancer Laboratory Deputy Director Genetic and Biology of Cancer Dpt Institut Curie - Inserm U830

  Dac EGAC00001000581

• DAC for the Prostate Cancer Lymph Node dataset

  Dac EGAC00001000586

• Functional Genomics Laboratory, Kolling Institute of Medical Research DAC - TP53 mutation data in ovarian cancer

  Dac EGAC00001000589

• The Ovarian Cancer Association Consortium Data Access Committee

  Dac EGAC00001000616

• DAC for study Treg in breast cancer and healthy individuals

  Dac EGAC00001000638

• DAC for NKTL study. National Cancer Centre Singapore.

  Dac EGAC00001000640

• MSI-Exome-DAC Team Microsatellites Instability and Cancer, INSERM Hospital Saint-Antoine, Paris 12, France Carte d'identité des tumeurs, French league against cancer, Paris France

  Dac EGAC00001000665

• DAC for "A Functional Network of Gastric-Cancer-Associated Splicing Events Controlled by Dysregulated Splicing Factors"

  Dac EGAC00001000675

• The NOWAC blood-breast cancer commitee data access agreement

  Dac EGAC00001000684

• DAC for Direct Detection of Early-stage Cancers Using Circulating Tumor DNA

  Dac EGAC00001000701

• RNA sequencing data of 66 matched primary and recurrent high grade serous ovarian cancer

  Dac EGAC00001000741

• Differential Presence of Exons in Cell-Free DNA Reveals Different Patterns in Colorectal Cancer Between Metastatic and Non-Metastatic Patients

  Dac EGAC00001000749

• The data access committee for Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer.

  Dac EGAC00001000757

• Singapore gastric cancer WGS

  Dac EGAC00001000888

• Cancer Pharmacogenetics Group at King's College London

  Dac EGAC00001000795

• UT MD Anderson Cancer Center Department of Genomic Medicine Lipoasarcoma Data Access Committee

  Dac EGAC00001000821

• Peter Mac Translational Breast Cancer Genomics and Therapeutics Lab Data Access Committee

  Dac EGAC00001000837

• MCCB Breast Cancer Data Access Committee

  Dac EGAC00001000854

• Breast cancer multi-region sequencing from Sottoriva Lab

  Dac EGAC00001000890

• Spatial Maps of Prostate Cancer Transcriptomes Data Access

  Dac EGAC00001000913

• The evolutionary history of human colitis-associated colorectal cancer

  Dac EGAC00001000917

• Harbin Medical University Cancer Hospital Data Access Commitee

  Dac EGAC00001000948

• Division of Cancer Genomics, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001000957

• DAC for study: Frequent mutation of the FOXA1 untranslated region in prostate cancer

  Dac EGAC00001000962

• Ludwig Data Access Committee for the Study of Oesophageal Cancer

  Dac EGAC00001000978

• DAC for CancerDetector study

  Dac EGAC00001000979

• The University of Hong Kong Gastric Cancer Organoids Genomics Study Data Access Committee

  Dac EGAC00001000981

• Stanford Data Access Committee for Breast Cancer Tumor Heterogeneity through Treatment

  Dac EGAC00001000993

• Colorectal Cancer Organoids Data Access Committee

  Dac EGAC00001000998

• Genome-wide association study of cervical cancer in East Asian populations

  Dac EGAC00001001024

• Data Access Commitee for gastric cancer ascites

  Dac EGAC00001001026

• Rectal Cancer Samples Data Access Committee

  Dac EGAC00001001034

• University of Florida Brain Cancer DAC

  Dac EGAC00001001035

• University Clinic Erlangen/ German Cancer Research Center rare tumors data access committee

  Dac EGAC00001001053

• Age-related remodeling of apparently normal esophageal epithelia by common cancer drivers

  Dac EGAC00001001067

• SNP array datas of "Matched" cancer/PNE

  Dac EGAC00001001069

• DAC for study: Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer

  Dac EGAC00001001082

• DAC for Familial Breast Cancer study EGAS00001003305

  Dac EGAC00001001087

• DAC for study Non-coding RNAs in Breast Cancer

  Dac EGAC00001001090

• DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"

  Dac EGAC00001001099

• DAC for Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines

  Dac EGAC00001001101

• Radboudumc Cancer Genomics DAC

  Dac EGAC00001001102

• DAC for MCO colorectal cancer genomics at UNSW

  Dac EGAC00001001122

• DAC for Genomic characterization of metastatic breast cancers

  Dac EGAC00001001129

• Korean Advanced Thyroid Cancer Data Access Commitee

  Dac EGAC00001001151

• DAC for GAMuT Project - Peter MacCallum Cancer Centre

  Dac EGAC00001001154

• Leeds Cancer Genomics

  Dac EGAC00001001156

• Children's Cancer Therapy Development Institute Data Access Commitee

  Dac EGAC00001001160

• Stanford Data Access Committee for Multi-Region WES of Metastatic Colorectal Cancer

  Dac EGAC00001001164

• Charbonneau Cancer Institute DAC

  Dac EGAC00001001165

• The data access committee for genome-wide cell-free DNA fragmentation in patients with cancer

  Dac EGAC00001001180

• OSBREAC (Oslo Breast Cancer Research Consortium)

  Dac EGAC00001001186

• Latency and interval therapy affect the evolution in metastatic colorectal cancer.

  Dac EGAC00001001198

• Gastric Cancer Pan-genome Data Access Commitee

  Dac EGAC00001001211

• Immune and Metabolic Features of Brain Metastases Melanoma (Cancer Discovery) Data Access Committee

  Dac EGAC00001001216

• Ewha-Samsumg Lung cancer collaboration DAC

  Dac EGAC00001001237

• DAC for Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness

  Dac EGAC00001001250

• UT MD Anderson Cancer Center Genomic Medicine and Leukemia

  Dac EGAC00001001252

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001001272

• SMC Colon cancer team

  Dac EGAC00001001277

• DAC for GAMuT Project - Peter MacCallum Cancer Centre

  Dac EGAC00001001278

• Charbonneau Cancer Institute DAC

  Dac EGAC00001001280

• Ewha-Samsung Lung cancer collaboration DAC

  Dac EGAC00001001283

• ASAN Center for Cancer Genome Discovery Data Access Commitee

  Dac EGAC00001001285

• High-grade serous ovarian cancer (MDACC) data access committee

  Dac EGAC00001001288

• DAC for HSTCL study. National Cancer Centre Singapore.

  Dac EGAC00001001302

• DAC for Angiosarcoma Study. National Cancer Centre Singapore.

  Dac EGAC00001001311

• DAC for MEITL study. National Cancer Centre Singapore.

  Dac EGAC00001001323

• The data access committee for Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer

  Dac EGAC00001001331

• UCL Cancer Institute Data Access Committee

  Dac EGAC00001001360

• ASAN Center for Cancer Genome Discovery Data Access Commitee

  Dac EGAC00001001391

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001404

• The University of Hong Kong Colon Cancer Organoids Genomics Study Data Access Committee

  Dac EGAC00001001405

• Cancer Sequencing Data Access Committee

  Dac EGAC00001001428

• Data access committee for white blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

  Dac EGAC00001001435

• Cancer Data Access Commitee

  Dac EGAC00001001436

• Yale Cancer Center Data Access Commitee

  Dac EGAC00001001437

• Hyperpolarized 13C MRI in breast cancer DAC

  Dac EGAC00001001438